Mirae Asset Global Etfs Holdings Ltd. Neuronetics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 16,724 shares of STIM stock, worth $32,946. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,724
Previous 19,760
15.36%
Holding current value
$32,946
Previous $68,000
36.76%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding STIM
# of Institutions
110Shares Held
21.7MCall Options Held
1.58MPut Options Held
213K-
Vanguard Group Inc Valley Forge, PA2.83MShares$5.58 Million0.0% of portfolio
-
Ubs Group Ag2.16MShares$4.26 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.82MShares$3.59 Million0.01% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$3.42 Million1.44% of portfolio
-
Wexford Capital LP Greenwich, CT1.18MShares$2.32 Million0.49% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $53.2M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...